Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Cash Flows from Operating Activities
Net Loss from Operations	$ (119,017,591)	$ (5,100,318)
Adjustments to Reconcile Net Loss to Net Cash Used in Operating Activities:
Depreciation	166,451	24,309
Amortization of Right-Of-Use Asset	611,253	333,543
Amortization of Debt Discount	50,871,869	18,772
Shared-based Compensation & Expense	134,192	1,564,376
Impairment on Promissory Note	421,754
Impairment on Life Insurance		104,978
PPP Loan Forgiveness		(64,502)
Foreign Exchange Transaction Gain	(1,403,859)	354,392
Unrealized Loss on Securities Investment	49,190,748	1,690,086
Realized Loss on Securities Investment	4,698,078
Loss on Equity Method Investment	51,999	227,643
Net Gain in the Unconsolidated Period		(61,346)
Changes in Operating Assets and Liabilities
Real Estate	4,810,464	4,227,504
Account Receivables	849,413	(1,629,544)
Prepaid Expense	399,442	(1,521,281)
Deposits	(16,361)	(226,487)
Trading Securities	(14,426,785)
Inventory	34,991	(36,873)
Accounts Payable and Accrued Expenses	9,663,367	416,947
Deferred Revenue	(2,199,477)	2,608,632
Operating Lease Liability	(293,525)	(329,404)
Builder Deposits	(1,230,783)	(1,182,933)
Income Tax Payable		(678,694)
Net Cash (Used in) Provided by Operating Activities	(16,684,360)	739,800
Net Cash Used in Discontinued Operating Activities		(422,188)
Net Cash (Used in) Provided by Operating Activities	(16,684,360)	317,612
Cash Flows from Investing Activities
Purchase of Fixed Assets	(227,821)	(21,674)
Purchase of Real Estate Properties	(25,362,146)
Proceeds from Global Opportunity Fund Liquidation		301,976
Sales of Investment Securities	110,718	2,102,048
Purchase of Investment Securities	(19,390,318)	(201,229)
Investment in Life Insurance		(200,000)
Sales of Investment Securities to Related Party	2,480,000
Cash Loss in Deconsolidation of American Pacific Bancorp	(1,235,953)
Issuing Loan Receivable - Related Party	(11,878,605)
Proceed form Loan Receivable - Related Party	(539,876)	(200,000)
Net Cash (Used in) Provided by Investing Activities	(56,044,001)	1,781,121
Net Cash Used in Discontinued Investing Activities
Net Cash (Used in) Provided by Investing Activities	(56,044,001)	1,781,121
Cash Flows from Financing Activities
Proceeds from Common Stock Issuance	104,565,659	13,202,123
Proceeds from Exercise of Subsidiary Warrants	3,249,339	11,380,460
Proceeds from Sale of Subsidiary Shares	280,000	3,097,791
Dividend Paid on Preferred Stock	(73,750)	(109,916)
Borrowings from M&T Loan		617,590
Borrowing from PPP Loan	68,502	68,502
Repayment of PPP Loan		(4,000)
Distribution to Non-controlling Interest Shareholders	(2,549,750)	(411,250)
Repayment to Notes Payable	(610,767)	(250,000)
Proceeds from Notes Payable - Related Parties	5,545,495	201,273
Proceeds Repayment to Notes Payable - Related Parties	(7,057,324)	(6,644,542)
Net Cash Provided by Financing Activities	103,417,404	21,148,031
Net Cash Provided by Discontinued Financing Activities
Net Cash Provided by Financing Activities	103,417,404	21,148,031
Net Increase in Cash and Restricted Cash	30,689,043	23,246,764
Effects of Foreign Exchange Rates on Cash	(1,622,343)	50,683
Cash and Restricted Cash - Beginning of Year	31,735,479	8,438,032
Cash and Restricted Cash- End of Period	60,802,179	31,735,479
Supplementary Cash Flow Information
Cash Paid for Interest	20,154	855,381
Cash Paid for Taxes	446,757	688,316
Supplemental Disclosure of Non-Cash Investing and Financing Activities
Unrealized (Loss) Gain on Investment	(57,179)	19,486
Initial Recognition of ROU / Lease Liability	256,928	762,239
Acquiring True Partner Stock by Issuing Promissory Note	10,003,689
Sales of Investment in Vivacitas to Related Party	2,279,872
Transactions under Common Control	57,190,499
Intrinsic Value of BCF	(50,770,192)
Converting Notes to Stock	64,226,566
American Pacific Bancorp Deconsolidation	27,904,857
Gain from Exercise of American Premium Water Warrant	734,400
Purchase of Fixed Asset by Issuing Promissory Note	95,000
Disposal of Impact BioMedical Inc. to Related Party		46,154,160
Disposal of iGalen International Inc. to Related Party		3,741,065
Contribution		945,769
Change in Non-Controlling Interest		$ 1,333,229